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The activation of group I metabotropic glutamate receptors
(mGluRs) produces a variety of actions that lead to alterations
in excitability and synaptic transmission in the CA1 region of the
hippocampus. The group I mGluRs, mGluR1 and mGluR5, are
activated selectively by (S)-3,5-dihydroxyphenylglycine
(DHPG). To identify which of these mGluR subtypes are respon-
sible for the various actions of DHPG in area CA1, we took
advantage of two novel subtype-selective antagonists. (S)-()-
-amino-a-methylbenzeneacetic acid (LY367385) is a potent
competitive antagonist that is selective for mGluR1, whereas
2-methyl-6-(phenylethynyl)-pyridine (MPEP) is a potent non-
competitive antagonist that is selective for mGluR5. The use of
these compounds in experiments with whole-cell patch-clamp
recording and Ca
2-imaging techniques revealed that each
group I mGluR subtype plays distinct roles in regulating the
function of CA1 pyramidal neurons. The block of mGluR1 by
LY367385 suppressed the DHPG-induced increase in intracel-
lular Ca
2 concentration ([Ca
2]i) and the direct depolarization
of CA1 hippocampal neurons. In addition, the increase in the
frequency of spontaneous IPSCs (sIPSCs) caused by the
DHPG-induced depolarization of inhibitory interneurons also
was blocked by LY367385, as was the DHPG-induced inhibi-
tion of transmission at the Schaffer collateral3CA1 synapse.
On the other hand, the block of mGluR5 by MPEP antagonized
the DHPG-induced suppression of the Ca
2-activated potas-
sium current (IAHP) and potentiation of the NMDA receptor.
Finally, antagonism of the DHPG-induced suppression of
evoked IPSCs required the blockade of both mGluR1 and
mGluR5. These data suggest that mGluR1 and mGluR5 play
distinct roles in the regulation of the excitability of hippocampal
CA1 pyramidal neurons.
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Metabotropic glutamate receptors (mGluRs) have been impli-
cated in a number of physiological and pathological responses to
glutamate in CA1 hippocampal region. These include the modu-
lation of neuronal excitability and synaptic transmission (for
review, see Anwyl, 1999) as well as the induction of long-term
potentiation (Bashir et al., 1993), generation of epileptiform ac-
tivity (Aronica et al., 1997; Merlin, 1999; Galoyan and Merlin,
2000), and postischemic injury (Bond et al., 1999, 2000;
Pellegrini-Giampietro et al., 1999). The family of mGluRs is
composed of three distinct groups that are based on sequence
homology, pharmacology, and coupling to second messenger sys-
tems (for review, see Nakanishi, 1992; Schoepp and Conn, 1993;
Pin and Duvoisin, 1995). Although all three groups of mGluRs
play roles in regulating hippocampal function (Anwyl, 1999),
group I mGluRs are especially important for the regulation of
pyramidal cell excitability. The group I mGluRs include mGluR1
and mGluR5, both of which are activated selectively by (S)-3,5-
dihydroxyphenylglycine (DHPG), and couple to Gq and to the
activation of phosphoinositide hydrolysis.
The activation of group I mGluRs has a number of direct
excitatory effects on CA1 pyramidal cells, including depolariza-
tion and increased cell ﬁring (Charpak et al., 1990; Desai and
Conn, 1991; Pedarzani and Storm, 1993; Davies et al., 1995;
Gereau and Conn, 1995b; Mannaioni et al., 1999). These effects
have been ascribed to the activation of Ca
2-activated and Ca
2-
independent cationic conductances (Crepel et al., 1994; Gueri-
neau et al., 1995) and the inhibition of at least four different K

currents. These include the AHP current (Charpak et al., 1990;
Desai and Conn, 1991), a leak current (Guerineau et al., 1994),
the M current (Charpak et al., 1990), and a voltage-dependent
slow-inactivating current (Luthi et al., 1996). In addition, the
activation of group I mGluRs increases CA1 pyramidal cell ex-
citability by decreasing GABA-mediated inhibition (Desai and
Conn, 1991; Gereau and Conn, 1995a; Fitzsimonds and Dichter,
1996).
Immunocytochemistry studies reveal that mGluR5 is localized
in CA1 pyramidal cells, whereas mGluR1a is not detectable
(Baude et al., 1993; Romano et al., 1995). Therefore, mGluR5 is
thought to play a predominant role in regulating CA1 pyramidal
cells. However, although mGluR5 is the most abundant group I
mGluR in CA1 pyramidal cells, these cells also express mGluR1
mRNA (Shigemoto et al., 1992; Berthele et al., 1998), and a
recent immunohistochemical study with antibodies that react with
all splice forms of mGluR1 revealed low levels of mGluR1 im-
munoreactivity in this region (Ferraguti et al., 1998). Therefore,
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regulating CA1 pyramidal cell function.
We have used new pharmacological tools to determine the
physiological roles of mGluR1 and mGluR5 in CA1 pyramidal
cells. We report that both mGluR1 and mGluR5 participate in
regulating synaptic transmission and pyramidal cell excitability in
hippocampal area CA1. However, each of these group I mGluR
subtypes has distinct physiological roles and shows little overlap.
Thus, although mGluR1 and mGluR5 are highly homologous and
display similar effector coupling, these receptors are functionally
distinct when present in a single neuronal population.
MATERIALS AND METHODS
Materials. (S)-3,5-dihydroxyphenylglycine (DHPG), 6-cyano-7-nitro-
quinoxaline-2,3-dione (CNQX), D()-2-amino-5-phosphonopentanoic
acid (D-AP5), (S)-()--amino-a-methylbenzeneacetic acid (LY367385),
and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) were obtained from
Tocris (Balwin, MO). QX 314 was purchased from Alomone Laborato-
ries (Jerusalem, Israel). The cell-impermeant ﬂuo-3 pentapotassium salt
was obtained from Molecular Probes (Eugene, OR). All other materials
were obtained from Sigma (St. Louis, MO).
Electrophysiological recording from rat hippocampal slices. Preparation
of hippocampal slices was performed as described previously (Marino et
al., 1998). Young rats [Sprague Dawley, age postnatal day (P) P15–P20]
were anesthetized deeply with isoﬂurane and decapitated. The brain was
removed rapidly and submerged in an ice-cold artiﬁcial CSF (aCSF) of
the following composition (in mM): 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25
NaH2PO4, 1 CaCl2, 3 MgCl, and 10 glucose saturated with 95% O2/5%
CO2, pH 7.4. The hemisected brain was glued onto the stage of a
vibrating microtome (Vibratome series 1000, Ted Pella, Redding, CA),
and sections of 300 m thickness were cut and stored in an incubation
chamber at room temperature for 1 hr before use. The Emory Univer-
sity Institutional Animal Care and Use Committee approved all
procedures.
Conventional blind and visually guided whole-cell patch recordings
were obtained from CA1 pyramidal neurons both in voltage-clamp and in
current-clamp conﬁguration with an Axopatch 200A (Axon Instruments,
Foster City, CA) and a pipette resistance of 5–7M . The solution used
to ﬁll the electrodes and the holding current in the voltage-clamp con-
ﬁguration varied with the different experimental approaches that were
used as described below. The standard recording solution was composed
of (in mM) 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25 NaH2PO4, 1.5 CaCl2,
1.5 MgCl and 10 glucose saturated with 95% O2/5% CO2, pH 7.4. All
neurons included in this study had a resting membrane potential below
55 mV (58  1.1; n  125) and an access resistance in the range of
10–20 M that showed only minimal variations during the recordings
that were included in this study. Records were ﬁltered at 5 kHz and
digitized at 20 kHz with a Digidata 1200 analog-to-digital board. All data
were acquired, stored, and analyzed on a PC with the pClamp and Origin
software (Axon Instruments and Microcal Software, Northampton, MA,
respectively) and the Mini Analysis Program (Synaptosoft, Leonia, NJ).
In all of the experiments the drugs were administered by addition to the
superfusing medium and were applied for a sufﬁcient period to allow for
their full equilibration. All of the data were collected at room temper-
ature (23–26°C).
Imaging of ﬂuo-3 ﬂuorescence. In the calcium-imaging experiments the
electrodes were ﬁlled with (in mM) 140 K-gluconate, 10 HEPES, 7 NaCl,
4 Mg-ATP, 0.3 Na3-GTP, and 100 M ﬂuo-3. To eliminate synaptic
activity, we added 1 M tetrodotoxin (TTX) to the aCSF. Throughout
the experiments 15 msec, 5 mV voltage steps were applied at 30 sec
intervals from a holding potential of 70 mV to monitor the holding
current, series resistance, and membrane input resistance continuously.
After entering whole-cell mode, the cells were maintained for 20 min
to allow for ﬁlling with ﬂuo-3 before image acquisition. After the base-
line period, DHPG was applied, and images were acquired every 5 sec
after a 25 msec exposure to 450–490 nm light. Fluorescence was re-
corded through a bandpass ﬁlter (500–550 nm) with a Princeton Micro-
max camera (Trenton, NJ). Fluorescence intensity was measured in cell
bodies by using the Axon Imaging Workbench program (v2.2.1; Axon
Instruments) and expressed as F/Fo, where Fo is the ﬂuorescence inten-
sity before drug treatment. Increases in ﬂuorescence 1.2-fold were
considered to be real changes. Baseline ﬂuorescence values possessed a
peak F/Fo ratio of 1.01  0.01 over a typical experiment (see Fig. 1C,
ﬁlled bar). Peaks of F/Fo ratio and of I holding during the DHPG
application were used as a measure of the actions of DHPG to remove
the variability associated with the time required for DHPG to reach cells
at different depths in the slices (see Fig. 1C,D).
Current-clamp experiments. Electrodes were ﬁlled with (in mM) 140
K-gluconate, 10 HEPES, 7 NaCl, 4 Mg-ATP, and 0.3 Na3-GTP. Standard
aCSF was used with the addition of 1 M TTX.
I–V relationship. Electrodes were ﬁlled with (in mM) 140 K-gluconate,
10 HEPES, 7 NaCl, 4 Mg-ATP, and 0.3 Na3-GTP. Standard aCSF was
used with the addition of (in M) 10 MPEP, 1 TTX, 10 bicuculline, 25
CNQX, and 50 AP-5. Depolarizing pulses (10 mV amplitude, 750 msec
long) were applied periodically to monitor membrane conductance, and
a chart recorder was used to monitor the holding current. The I–V
relationship was assessed by ramping the membrane potential from 10
to 130 mV (20 mV/sec) before drug application and at the time of
maximal DHPG-induced inward current. Voltage-dependent calcium
currents were inactivated by holding the membrane potential at 10 mV
for 1 sec before initiating the ramp.
Ca
2-activated potassium current (IAHP) measurements. For measure-
ment of IAHP the aCSF contained 0.5 M TTX, 1 mM tetraethylammo-
nium (TEA), 10 M bicuculline, and 2.5 mM CaCl2. Electrodes were
ﬁlled with (in mM) 140 K-methylsulfate, 10 HEPES, 2 Na2-ATP, 3
MgCl2, and 0.4 Na3-GTP. IAHPwas elicited once every 60 sec by applying
100–200 msec depolarizing steps to 60 and to 70 mV from a holding
potential of 50 mV. This depolarizing step elicits a robust, unclamped
Ca
2 action current (Pedarzani and Storm, 1993; Stocker et al., 1999),
and IAHP was measured as the outward tail current that immediately
followed the depolarizing step. The access resistance and the amplitude
and time course of the Ca
2 current during the step were monitored
continuously and showed only minimal variations during the recordings
that were included in this study.
NMDA-evoked currents. Measurement of NMDA-evoked currents was
performed as described previously (Marino et al., 1998; Alagarsamy et
al., 1999). NMDA (100 M) was applied directly above the recording site
by a modiﬁed U-tube application system. NMDA-evoked currents were
recorded from a holding potential of 60 mV in slices bathed in aCSF
containing 0.5 M TTX. The percentage of potentiation was deﬁned by
using the ratio of maximum current amplitude during DHPG application
(Imax) to the average current amplitude of three trials immediately
preceding the drug application (Ibase) in the equation: % potentiation 
[((Imax/Ibase)  1)  100]. Patch solution was identical to the K-gluconate
solution described above except that the K-gluconate was replaced with
Cs-methanesulfonate.
Measurement of IPSCs. For recordings of monosynaptic IPSCs and
spontaneous IPSCs, electrodes were ﬁlled with (in mM) 120 CsCl, 10
HEPES, 4 Mg-ATP, 0.3 Na3-GTP, and 5 QX 314. IPSCs were evoked
from a holding potential of 70 mV by stimulation at a frequency of 0.1
Hz through a bipolar stimulating electrode (240 m spacing; FHC,
Bowdoinham, ME). Stimulating electrodes were placed within 100 mo f
the patched cell. The ionotropic glutamate receptor blockers AP-5 (50
M) and CNQX (25 M) were included in all of the IPSC studies.
Because of the high intracellular chloride current, IPSCs were inward
currents at 70 mV.
Spontaneous IPSCs were detected automatically. Both the frequency
and the peak amplitude of detected events were analyzed. The GABAA
receptor blocker bicuculline (10 M) was added routinely at the end of
experiments to verify that both the evoked IPSCs and the spontaneous
IPSCs were abolished completely, conﬁrming that they were GABAA
receptor-mediated.
Measurement of EPSCs and paired pulse facilitation recording. For the
recording of evoked EPSCs and paired pulse facilitation, electrodes were
ﬁlled with (in mM) 140 K-gluconate, 10 HEPES, 7 NaCl, 4 Mg-ATP, and
0.3 Na3-GTP. Pairs of EPSCs were evoked from a holding potential of
60 mV by stimulation at a frequency of 0.06 Hz with an interpulse
interval of 100 msec. Stimuli were delivered through a bipolar stimulating
electrode (240 m spacing; FHC) placed in the stratum radiatum within
100 m of the patched cell. Standard aCSF was used with the addition of
bicuculline (10 M); a preventive cut between areas CA3 and CA1 was
made to avoid recurrent excitation. The AMPA receptor blocker CNQX
(25 M) was added routinely at the end of the experiments to verify that
the evoked EPSCs were abolished completely, conﬁrming that they were
AMPA receptor-mediated.
Statistical analysis. All numerical data are expressed as means  SEM.
Data were analyzed statistically by paired or unpaired Student’s t test or
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statistically signiﬁcant.
RESULTS
The highly selective, noncompetitive mGluR5 antagonist MPEP
has been shown previously to inhibit recombinant mGluR5 with
an IC50 value of 39 nM with no detectable effect on mGluR1-
mediated responses at much higher concentrations (Gasparini et
al., 1999). The highly selective, competitive mGluR1 antagonist
LY367385 has been found to block responses selectively to re-
combinant mGluR1a with an IC50 value of 8.8 M and with no
detectable effect on mGluR5-mediated responses (Clark et al.,
1997). Therefore, these compounds were used to determine which
group I mGluR underlies the calcium responses and direct exci-
tatory effects of DHPG onto CA1 hippocampal pyramidal neu-
rons, as well as DHPG-induced modulation of the inhibitory
transmission in CA1 hippocampal area.
mGluR1 mediates the DHPG-induced increase
in [Ca
2]i and depolarization in CA1
hippocampal neurons
A common response to the activation of group I mGluRs that has
been observed in both recombinant and native systems is the
release of calcium from internal stores. Consistent with this and
with previous studies in hippocampal pyramidal cells (Abe et al.,
1992; Pozzo-Miller et al., 1996; Bianchi et al., 1999), DHPG
induced a robust increase in ﬂuorescence in CA1 pyramidal cells
that were loaded with the calcium-sensitive dye ﬂuo-3. DHPG (30
M) elicited a robust increase in ﬂuo-3 ﬂuorescence in both the
soma (Fig. 1A,C, left panels, D) and the dendrites (data not
shown) of all of the cells that were examined, suggesting that this
treatment increases intracellular [Ca
2]. Also consistent with
previous studies (Guerineau et al., 1995), simultaneous voltage-
clamp recordings in the same neurons revealed a DHPG-induced
inward current in CA1 pyramidal cells (Fig. 1B, left panel, E).
Surprisingly, neither of these effects of DHPG was blocked by
maximal concentrations of the mGluR5-selective antagonist
MPEP (10 M) (Fig. 1A–C, middle panels, D,E), suggesting that
mGluR5 plays little or no role in these group I-mediated responses.
In contrast, the mGluR1-selective antagonist LY367385 (100 M)
completely blocked the DHPG-induced increase in the ﬂuo-3 ﬂu-
orescence (Fig. 1A,C, right panels, D) and signiﬁcantly reduced the
DHPG-induced inward current (Fig. 1B, right panel, E).
The DHPG-induced inward current underlies the previously
described 1-aminocyclopentane-1,3-dicarboxylic acid (ACPD)
and DHPG-induced depolarization of CA1 pyramidal neurons
recorded in current-clamp mode (Desai and Conn, 1991; Gereau
and Conn, 1995b; Mannaioni et al., 1999). Figure 1F summarizes
the depolarizing effect of 30 M DHPG application (Vm of 4.2 
0.3 mV; n  18) on CA1 pyramidal cells. Consistent with the
voltage-clamp studies, DHPG-induced depolarization was not
blocked by 10 M MPEP (Vm of 4.6  1.1 mV; n  10) (Fig. 1F,
open bar). Because the slight DHPG-induced inward current that
remained in the presence of 100 M LY367385 could be sufﬁcient
for a substantial depolarization, we slightly increased the concen-
tration of this competitive mGluR1 antagonist used in the current-
clamp experiments. Consistent with the voltage-clamp studies, the
DHPG-induced depolarization was blocked completely by 300 M
LY367385 (Vm of 1.20  0.1 mV; n  5) (Fig. 1F).
In other brain regions, group I mGluR activation depolarizes
neurons by modulating a variety of conductances. Notably, in
hippocampal area CA3 DHPG depolarizes neurons by the inhi-
bition of a leak potassium conductance (Guerineau et al., 1994) or
by an increase in a nonselective cationic conductance (Guerineau
et al., 1995). The DHPG-induced inward current was associated
Figure 1. mGluR1 mediates the DHPG-
induced increase in [Ca
2]i and inward
currents simultaneously recorded from
CA1 hippocampal neurons. A, B,T i m e
course of the effect of 30 M DHPG alone
(left) and in the presence of 10 M MPEP
(middle)o r1 0 0M LY367385 (right)o n
ﬂuo-3 ﬂuorescence and on holding cur-
rent obtained in four different CA1 pyra-
midal neurons. Each symbol represents a
different cell. Antagonists and 1 M TTX
were applied for 10 min before the record-
ings were started. The horizontal bars for
drug application in A also apply to B. C,A
typical example of mGluR-mediated in-
crease in somatic ﬂuo-3 ﬂuorescence mea-
sured in three different CA1 pyramidal
neurons. Shown are DHPG alone (left)o r
in the presence of 10 M MPEP (middle)
or 100 M LY367385 (right). D–F, Bar
graphs expressing the highest values of
F/Fo ratio of ﬂuo-3 ﬂuorescence (D), peak
inward current (E), and peak depolariza-
tion (F) induced by DHPG application
alone or in the presence of 10 M MPEP
or 100–300 M LY367385. Values are the
means  SEM; n  4i nD and E and is
indicated in parentheses in F.* p 	 0.05;
**p 	 0.01; Student’s t test.
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(Fig. 2A). This suggests that an inhibition of a leak potassium
conductance is the most likely mechanism underlying this effect.
We therefore examined the current–voltage relationship of the
mGluR1-mediated inward current. Application of DHPG (30
M) in the presence of the mGluR5 blocker MPEP (10 M)
induced a change in the slope of the whole-cell current–voltage
relationship (Fig. 2B). Subtracting the predrug I–V trace from the
trace in the presence of DHPG reveals a near-linear I–V relation-
ship for the DHPG-induced current that reverses near the calcu-
lated potassium equilibrium potential in three of the four cells
that were tested (104.5  8 mV; n  3) (Fig. 2B, inset),
suggesting that the activation of mGluR1 depolarizes CA1 pyra-
midal cells by an inhibition of a leak potassium conductance.
Taken together, these data suggest that the DHPG-induced
increase in intracellular calcium concentration and the DHPG-
induced inward current and depolarization in CA1 hippocampal
neurons are mediated by mGluR1 and not by mGluR5.
mGluR5 mediates the DHPG-induced suppression of
IAHP and potentiation of NMDA receptor currents in
CA1 pyramidal neurons
The ﬁnding that DHPG-induced calcium transients and depolar-
ization of CA1 pyramidal cells is mediated by mGluR1 alone was
surprising in light of previous studies that revealed that mGluR5
is expressed abundantly in these neurons. However, DHPG in-
duces a number of other physiological responses in these cells,
some of which could be mediated by mGluR5. Two of the most
prominent effects of DHPG in these cells are the inhibition of
IAHP and the potentiation of NMDA receptor currents. Thus, we
determined the effects of the mGluR1 and mGluR5-selective
antagonists on each of these responses to DHPG. As reported
previously (Gereau and Conn, 1995b), DHPG (30 M) sup-
pressed IAHP in a reversible manner (73.2  3% of control) (Fig.
3A,C). Application of the selective mGluR5 antagonist MPEP
(10 M) completely blocked the DHPG-induced suppression of
IAHP (Fig. 3B), whereas the selective mGluR1 antagonist
LY367385 (100 M) had no effect (Fig. 3C). Neither of the
antagonists had an effect on the amplitude of IAHP when applied
alone.
We also investigated which group I mGluR subtype mediates
the DHPG-induced potentiation of NMDA-induced currents.
Consistent with previous studies (Aniksztejn et al., 1991, 1992;
Fitzjohn et al., 1996; Pisani et al., 1997), the bath application of
DHPG (30 M) increased the peak amplitude of the current
induced by fast local application of NMDA (100 M) (Fig. 4A, top
panels). The potentiation of NMDA receptor currents was inhib-
ited by preincubation with MPEP (Fig. 4A–C), but not by
LY367385 (Fig. 4C).
Figure 2. DHPG-induced inward current and depolarization in CA1
hippocampal neurons most likely are mediated by decreasing a leak
potassium conductance. A, The mGluR1-mediated inward current ob-
served in CA1 pyramidal neurons is associated with a decrease in mem-
brane conductance (top vs bottom trace). B, This decrease in membrane
conductance is evident in the whole-cell current–voltage relation. The
inset shows the subtraction of the currents that reveals a linear I–V
relationship, which is inward at normal resting potentials and reverses
near the predicted potassium equilibrium potential. Axis titles in B apply
in the inset.T h eﬁgure is representative of the results that were observed
in three of four cells.
Figure 3. The DHPG-induced suppression of IAHP in CA1 pyramidal
neurons is mediated by mGluR5. A, Time course from a single experi-
ment showing the suppression of IAHP induced by the application of 30
M DHPG. Letters indicate the time of the corresponding traces that are
shown at the top. B, The 10 min preapplication of 10 M MPEP antago-
nizes the DHPG-induced suppression of IAHP. C, Bar graph summarizing
mean data showing that the DHPG-induced suppression of IAHP is
blocked selectively by MPEP but is not altered by preincubation with the
mGluR1-selective antagonist LY367385 (100 M). The number of cells
that have been tested is in parentheses; values are the means  SEM of the
data, expressed as a percentage of control IAHP peak values. *p 	 0.05
versus control; Student’s t test.
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spontaneous IPSCs is mediated by mGluR1
In addition to its direct actions on CA1 pyramidal cells, the
activation of group I mGluRs impacts CA1 pyramidal cell excit-
ability indirectly by regulating GABA-mediated inhibitory trans-
mission. Two distinct effects of group I mGluR activation on
inhibitory transmission can be seen in recordings from CA1
pyramidal cells. First, group I mGluR agonists induce depolar-
ization and increase ﬁring of inhibitory interneurons (McBain et
al., 1994; van Hooft et al., 2000), leading to a robust increase in
spontaneous IPSCs. Second, group I mGluR agonists reduce the
amplitude of evoked monosynaptic IPSCs (Desai et al., 1994;
Gereau and Conn, 1995a). Activation of group I mGluRs does
not alter the amplitude of miniature IPSCs, suggesting that the
reduction of evoked IPSCs is mediated by a presynaptic action.
However, analysis of the effect of mGluR activation on monosyn-
aptic
IPSCs is complicated by the high frequency of DHPG-induced
spontaneous IPSCs. Thus, we took advantage of the mGluR1 and
mGluR5-selective antagonists to determine whether we could
differentiate between these two actions of DHPG.
Figure 5A, left, shows examples of sIPSCs recorded under
control conditions and during the bath application of 10 M
DHPG. Similar to results reported previously in area CA3 (Miles
and Poncer, 1993) and in rat frontal cortex (Chu and Hablitz,
1998), the application of DHPG (10 M) increased the frequency
of sIPSCs in all of the cells that were tested (n  4). These effects
were reversible on drug washout from the recording chamber
(data not shown). Preincubation with the mGluR5-selective an-
tagonist MPEP (10 M) did not block the DHPG-induced in-
crease in sIPSC frequency (Fig. 5A, middle), whereas preincuba-
tion with the selective mGluR1 antagonist LY367385 (100 M)
completely blocked this effect (Fig. 5A, right). DHPG produced a
leftward shift of the cumulative probability distributions of sIPSC
inter-event intervals (Fig. 5B, left), indicating a DHPG-induced
increase in the frequency of sIPSCs. This effect was blocked by
LY367385, but not by MPEP (Fig. 5B, right and middle, respec-
tively). The average frequency was calculated for each cell, and
the means of these values are shown in Figure 5D. Application of
10 M DHPG induced a signiﬁcant increase in mean frequency
(Fig. 5D, left). Preincubation with either MPEP or LY367385
alone did not change the mean frequency of sIPSCs signiﬁcantly;
however, LY367385 blocked the DHPG-induced increase in
sIPSC frequency, whereas MPEP was without effect (Fig. 5D,
right and middle, respectively). In contrast, the application of 10
M DHPG alone or in combination with the subtype-selective
antagonists produced no signiﬁcant effect on sIPSC amplitude
(Fig. 5C, left, middle, right). This is consistent with the previously
reported lack of effect of DHPG on mIPSC amplitude (Gereau
and Conn, 1995a) and suggests that DHPG does not alter
postsynaptic GABAA receptor currents.
Activation of both mGluR1 and mGluR5 reduces
evoked monosynaptic IPSCs
The activation of group I mGluRs also has been demonstrated to
induce a reduction in evoked monosynaptic IPSCs (Desai et al.,
1994; Gereau and Conn, 1995a). Consistent with this, the bath
application of DHPG (10 M) produced a reversible depression
of IPSCs by 80  4% (means  SEM) of baseline amplitude (Fig.
6A,E) that was antagonized only partially by preincubation with
LY367385 (100 M;4 8 9% of baseline amplitude; means 
SEM) (Fig. 6B) or MPEP (10 M;5 4 10% of baseline ampli-
tude; means  SEM) (Fig. 6C). However, preincubation with a
combination of LY367685 (100 M) and MPEP (10 M)f u l l y
blocked the DHPG-induced suppression of evoked IPSCs (7 
2% of baseline amplitude) (Fig. 6D,E). These data suggest that
the group I mGluR-induced suppression of monosynaptic IPSCs
is mediated by both mGluR1 and mGluR5. Therefore, DHPG
induces an increase in sIPSC frequency by the activation of
mGluR1 and an inhibition of evoked IPSCs by activation of both
mGluR1 and mGluR5.
Activation of mGluR1 reduces evoked EPSCs via a
presynaptic mechanism
Previous studies have demonstrated that multiple mGluRs mod-
ulate excitatory synaptic transmission. In particular, the group
I-selective agonist DHPG has been shown to induce a presynap-
tically mediated depression of excitatory transmission at the
Schaffer collateral3CA1 synapse (Gereau and Conn, 1995a;
Rodriguez-Moreno et al., 1998). Consistent with these previous
reports, 30 M DHPG induced a 54  5% (means  SEM)
Figure 4. MPEP antagonizes the DHPG-induced potentiation of
NMDA currents in CA1 pyramidal cells. A, Representative traces dem-
onstrate the DHPG-induced potentiation of NMDA currents (top traces)
and its block by preincubation with 10 M MPEP (bottom traces). B,
Average time course showing the effect of DHPG (open circles) and its
antagonism by 10 M MPEP ( ﬁlled circles). C, Bar graph showing the
mean effect of DHPG on NMDA current alone and in the presence of
MPEP or LY367385. The number of cells that have been tested is in
parentheses; values are the means  SEM of the data, expressed as peak
potentiation of control values. *p 	 0.05; Student’s t test.
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stratum radiatum (Fig. 7A). We used LY367385 and MPEP to
determine which of the group I mGluRs mediate this response.
Interestingly, we found that the DHPG-induced suppression of
transmission at the Schaffer collateral3CA1 synapse was not
affected by preincubation with MPEP (10 M) but was antago-
nized completely by the preapplication of LY367385 (300 M)
(Fig. 7B,C, respectively). Moreover, in experiments in which
paired pulse facilitation was measured, DHPG induced a 46.3%
increase in the paired pulse ratio (PPR), which was signiﬁcant,
and reversed with the washout of the drug (PPR predrug, 2.08 
0.16; DHPG, 3.03  0.37; p 	 0.05, paired t test; n  9) (Fig. 8).
This effect on PPR was antagonized by preincubation with 300
M LY367385 (DHPG alone, 46.3  15%; n  9; DHPG plus
LY367385, 6.3  2.1%; n  7; p 	 0.05; t test) but was not affected
by 10 M MPEP (DHPG alone, 46.3  15%; n  9; DHPG plus
MPEP, 32.4  10.4%; n  9; p  0.05; t test) (Fig. 8). Because an
increase in PPR is generally indicative of a presynaptic mecha-
nism, these results suggest that the mGluR1 activation suppresses
excitatory transmission at the Schaffer collateral3CA1 synapse
via a presynaptic mechanism.
DISCUSSION
Previous studies have revealed that the activation of group I
mGluRs has a number of actions on hippocampal CA1 pyramidal
cells that increase excitability and synaptic excitation of these
neurons. These include direct depolarization (Charpak et al.,
1990; Desai and Conn, 1991; Davies et al., 1995; Mannaioni et al.,
1999), reduction in the slow afterhyperpolarization (Pedarzani
and Storm, 1993; Abdul-Ghani et al., 1996), and potentiation of
NMDA receptor currents (Aniksztejn et al., 1991, 1992; Fitzjohn
et al., 1996). In addition, the activation of group I mGluRs
decreases evoked synaptic inhibition in area CA1 (Gereau and
Conn, 1995a). This combination of effects can act to increase the
net excitatory drive through this portion of the hippocampal
circuit. Although the speciﬁc group I mGluR subtypes that me-
diate each of these effects have not been determined, mGluR5 has
been considered to be the most likely candidate for the receptor
responsible for the actions of group I mGluR agonists on CA1
pyramidal cells because of its high abundance in these neurons
(Luja ´n et al., 1996). In addition, although some splice variants of
mGluR1 are present at lower levels in CA1 pyramidal cells, it has
been assumed that these two receptors serve similar roles because
both mGluR1 and mGluR5 couple to Gq and to the activation of
phosphoinositide hydrolysis.
The most important ﬁnding of the present study is that
mGluR1 and mGluR5 do not serve similar or redundant roles in
CA1 pyramidal cells but, rather, that the roles of these receptors
are highly segregated. The ﬁnding that DHPG-induced somatic
calcium transients are mediated exclusively by mGluR1 was es-
pecially surprising, because both mGluR1 and mGluR5 couple to
the activation of phosphoinositide hydrolysis and inositol
trisphosphate-mediated calcium release in other systems. It
should be noted that measurements of calcium transients in soma
and proximal dendrites in these studies do not rule out the
possibility that mGluR5 activation induces calcium release in
small subcellular compartments (such as distal dendrites or
spines) that were not detected in these studies. However, regard-
less of the reason for the lack of a calcium response to mGluR5
activation, these ﬁndings, along with the other data that have
been reported, reveal that mGluR1 and mGluR5 display a high
speciﬁcity of function when present in the same neuronal
population.
Until recently, the selective tools required for determining the
functions of mGluR1 and mGluR5 in native preparations have
Figure 5. mGluR1 mediates the DHPG-induced in-
crease in the frequency of pharmacologically isolated
spontaneous IPSCs (sIPSCs) in CA1 pyramidal neu-
rons. A, Four consecutive traces under the control con-
dition (top left) and during the bath application of 10 M
DHPG (bottom left) demonstrate the DHPG-induced
increase in sIPSCs. This effect was not altered by
DHPG preincubation with MPEP (top middle, bottom
middle) but was decreased signiﬁcantly by preincubation
with LY367385 (top right, bottom right). Traces are rep-
resentative of results obtained in four independent ex-
periments for each condition. B, Cumulative probability
plots demonstrate the effect of DHPG on sIPSC inter-
event interval. DHPG applied alone (left) or after pre-
incubation with MPEP (middle) caused a signiﬁcant
shift in the inter-event interval distributions toward a
shorter interval, indicating a signiﬁcant increase in the
frequency of sIPSCs [Kolmogorov–Smirnov (K–S) sta-
tistic; p 	 0.01]. The mGluR1-selective antagonist
LY367385 completely antagonized this DHPG-
mediated effect (right;K –S statistic; p  0.05). C,C u -
mulative probability plots demonstrate the lack of effect
of DHPG on sIPSC amplitude in all of the conditions
that were tested (K–S statistic; p  0.05). D, Bar graph
showing the increase in the frequency of sIPSCs, in-
duced by DHPG alone and in the presence of MPEP or
LY367385. Note that antagonist alone has no effect on
the mean frequency ( ﬁlled bars). The number of cells
that have been tested is in parentheses; values are the
means  SEM. *p 	 0.05 versus control; Student’s t test.
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gests distinct roles for mGluR1 and mGluR5 when these recep-
tors are present in the same neurons. For instance, neurons in the
subthalamic nucleus (STN) contain both mGluR1 and mGluR5,
and DHPG induces membrane depolarization and oscillations in
these cells (Awad et al., 2000). However, this response to DHPG
is mediated exclusively by mGluR5, with no deﬁned role for
mGluR1. Conversely, GABAergic neurons in the substantia nigra
pars reticulata (SNr) express both mGluR1 and mGluR5, but
depolarization of these neurons is mediated exclusively by
mGluR1 (Marino et al., 1999). At present, the roles of mGluR1
and mGluR5 in STN and SNr neurons, respectively, are not
known. However, the studies that have been reported make it
clear that these receptors are not playing redundant roles in these
neuronal populations.
At present, the molecular mechanisms involved in the segrega-
tion of function of mGluR1 and mGluR5 are not clear. However,
because these two receptor subtypes are generally capable of
coupling to the same GTP effector proteins (i.e., Gq), it is possible
that the receptors have differential access to signaling partners.
For instance, mGluR1 might be localized in close proximity to
leak potassium channels and inositol trisphosphate receptors,
whereas mGluR5 is coupled functionally to NMDA receptors
and potassium channels that are responsible for the AHP current.
Recent evidence suggests that mGluR5 and NMDA receptors
may interact physically via interactions with a series of scaffolding
proteins that include Homer, Shank, PSD-95, and others (Ehlers,
1999; Naisbitt et al., 1999; Tu et al., 1999). A key component of
this interaction is the binding of mGluR5 to Homer. Homer is
known to interact with the group I mGluRs via a speciﬁc se-
quence found in the C-terminal portion of the receptor (Tu et al.,
1998). Although both splice forms of mGluR5 can bind to Homer,
mGluR1a is the only mGluR1 splice form that contains the
Homer binding domain (Houamed et al., 1991; Masu et al., 1991;
Pin et al., 1992; Tanabe et al., 1992). Because the mGluR1a splice
variant is not present in CA1 pyramidal cells (Shigemoto et al.,
1992; Hampson et al., 1994; Berthele et al., 1998), the splice forms
that are present in these neurons may not be capable of this
interaction. It is conceivable that other signaling complexes exist
that include mGluR1 and associated signaling partners. It is also
possible that some of the differences between mGluR1 and
mGluR5 actions are attributable to differential coupling to spe-
ciﬁc G-protein subunits that are present in CA1 pyramidal cells.
Indeed, early studies in recombinant systems revealed that,
whereas group I mGluRs couple primarily to Gq, these receptors
can couple to Gs in several cell types (Aramori and Nakanishi,
1992; Joly et al., 1995). Interestingly, some cell types are permis-
sive for mGluR1 coupling to Gs but restrict mGluR5 coupling to
Figure 6. Both mGluR1 and mGluR5 play a role in the
DHPG-induced decrease in monosynaptic evoked IP-
SCs. A–C, Time course of the DHPG-induced decrease
in IPSC amplitude (means  SEM) alone (A) and in the
presence of LY367385 (100 M; B) or MPEP (10 M;
C). IPSCs are normalized to predrug values. Sample
traces (at top) were obtained before (left), during (mid-
dle), and after the washout of DHPG (right) and repre-
sent averages of 10 traces. D, Time course of the effect
of DHPG on IPSC amplitude (means  SEM) in the
presence of the combined group I antagonists demon-
strates that blockade of both mGluR1 and mGluR5 is
necessary to inhibit fully the DHPG-induced suppres-
sion of inhibitory transmission. E, Bar graphs represent-
ing mean peak IPSC depression during DHPG applica-
tion alone and in the presence of MPEP, LY367385, and
the combination. Mean data represent the means of the
lowest values during DHPG application expressed as a
percentage of predrug values. The number of cells is
indicated in parentheses. Values are the means  SEM.
*p 	 0.05 versus control; Student’s t test.
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these two receptors is not identical and raises the possibility that
the different actions of these receptor subtypes are deﬁned in part
by the G-protein subunits.
It is important to point out that our ﬁnding that the depolar-
ization of CA1 pyramidal cells in rats is mediated by mGluR1
differs from the conclusion of Lu and colleagues (Lu et al., 1997),
who found that the depolarization induced by 1S,3R-ACPD is
absent in CA1 pyramidal cells from mGluR5 knock-out mice.
Although we do not have an explanation for this difference, it is
possible that this represents a species difference between rats and
mice. Also, it is possible that there is a developmental compen-
sation in the knock-out animals such that the role of mGluR1 is
altered in the absence of mGluR5 expression. Finally, there also
might be a developmental regulation of the receptors that medi-
ates this response. In the present studies we restricted our analysis
to young animals (P15–P20). Group I mGluRs are known to be
regulated tightly during postnatal development, and it is possible
that the receptor that mediates this response could be different in
the older animals used by Lu and colleagues (Lu et al., 1997). In
future studies it will be useful to use these new pharmacological
tools in wild-type mice as well as in mGluR5 and mGluR1
knock-out animals across developmental stages to differentiate
among these possibilities.
The ﬁnding that the DHPG-induced increase in the frequency
of spontaneous IPSCs is mediated by mGluR1 is consistent with
previous ﬁndings that mGluR1a is expressed heavily in the stra-
tum oriens/alveus interneurons (Baude et al., 1993; Luja ´n et al.,
1996; Shigemoto et al., 1997). The activation of group I mGluRs
induces a robust depolarization of these neurons (Miles and
Poncer, 1993; McBain et al., 1994; van Hooft et al., 2000) that
could contribute to the DHPG-induced increase in sIPSCs.
These ﬁndings must be kept in mind when interpreting the role
that mGluR1 plays in the modulation of evoked IPSCs as dem-
onstrated in the present study. It is possible that an mGluR1-
mediated direct depolarization of interneurons effectively could
reduce the ability of an electrical stimulus to evoke an IPSC
without affecting transmitter release at the level of the terminal.
It has been known for some time now that the activation of
group I mGluRs inhibits excitatory transmission at the Schaffer
collateral3CA1 synapse and that this inhibition of transmission
occurs via a presynaptic mechanism (Gereau and Conn, 1995a;
Rodriguez-Moreno et al., 1998). However, it has been difﬁcult to
predict which group I mGluR might mediate this response, be-
cause immunocytochemical studies have not been able to detect
mGluR1 or mGluR5 presynaptically localized in area CA1
(Baude et al., 1993; Luja ´n et al., 1996; Shigemoto et al., 1997).
Interestingly, we have found that this decrease in excitatory drive
through the hippocampal circuit is mediated by mGluR1. Pres-
ently, it is unclear whether the activation of presynaptic mGluR1
by glutamate release also would activate postsynaptic mGluR1 to
mediate a localized increase in input resistance, depolarization,
and Ca
2 release. Understanding the temporal–spatial nature of
synaptic mGluR1 signaling in CA1 pyramidal cells will be neces-
sary before the role of this receptor can be appreciated fully.
Our ﬁnding that mGluR1 and mGluR5 play different and
nonoverlapping roles in CA1 pyramidal cells has a number of
physiological and therapeutic implications. For instance, selective
antagonists of mGluR5 might be useful as novel anticonvulsant
agents by selectively reducing mGluR-mediated disinhibition and
inhibition of the AHP current. Such compounds would leave the
mGluR1-mediated excitation of inhibitory interneurons intact,
which could provide a therapeutic advantage. Consistent with
this, it was reported recently that selective mGluR5 antagonists
have robust anticonvulsant actions in rats (Chapman et al., 2000).
Conversely, the ﬁnding that mGluR5 is responsible for the po-
tentiation of NMDA receptor currents raises the possibility that
agonists of this receptor could be useful as cognitive-enhancing
agents or novel antipsychotic agents that act by selectively en-
hancing NMDA receptor function. The combined use of
mGluR1- and mGluR5-selective reagents for studies at the be-
havioral, systems, and cellular levels eventually should allow for a
detailed understanding of the physiological roles and therapeutic
Figure 7. The DHPG-induced inhibition of transmission at the Schaffer
collateral3CA1 synapse is mediated by mGluR1. A–C, Time courses of
the DHPG-induced decrease in evoked EPSC amplitude alone (A)o ri n
the presence of 10 M MPEP (B)o r1 0 0M LY367385 (C). Consistent
with mediation by mGluR1, the effect of DHPG is blocked fully by the
preapplication of LY367385. Each point represents the average amplitude
of four evoked responses acquired during 1 min by stimulation once every
15 sec. Data are presented as the means  SEM of n  11 cells (A), n 
9 cells (B), and n  7 cells (C). EPSCs were normalized to predrug
values. Sample traces (at top in each panel) were obtained before (left),
during (middle), and after (right) DHPG application.
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other CNS circuits.
REFERENCES
Abdul-Ghani MA, Valiante TA, Carlen PL, Pennefather PS (1996)
Metabotropic glutamate receptors coupled to IP3 production mediate
inhibition of IAHP in rat dentate granule neurons. J Neurophysiol
76:2691–2700.
Abe T, Sugihara H, Nawa H, Shigemoto R, Mizuno N, Nakanishi S
(1992) Molecular characterization of a novel metabotropic glutamate
receptor mGluR5 coupled to inositol phosphate/Ca
2 signal transduc-
tion. J Biol Chem 267:13361–13368.
Alagarsamy S, Marino MJ, Rouse ST, Gereau 4th RW, Heinemann SF,
Conn PJ (1999) Activation of NMDA receptors reverses desensitiza-
tion of mGluR5 in native and recombinant systems. Nat Neurosci
2:234–240.
Aniksztejn L, Bregestovski P, Ben-Ari Y (1991) Selective activation of
quisqualate metabotropic receptor potentiates NMDA but not AMPA
responses. Eur J Pharmacol 205:327–328.
Aniksztejn L, Otani S, Ben-Ari Y (1992) Quisqualate metabotropic re-
ceptors modulate NMDA currents and facilitate the induction of long-
term potentiation through protein kinase C. Eur J Neurosci 4:500–505.
Anwyl R (1999) Metabotropic glutamate receptors: electrophysiological
properties and role in plasticity. Brain Res Rev 29:83–120.
Aramori I, Nakanishi S (1992) Signal transduction and pharmacological
characteristics of a metabotropic glutamate receptor, mGluR1, in trans-
fected CHO cells. Neuron 8:757–765.
Aronica EM, Gorter JA, Paupard MC, Grooms SY, Bennett MVL,
Zukin RS (1997) Status epilepticus-induced alterations in metabo-
tropic glutamate receptor expression in young and adult rats. J Neurosci
17:8588–8595.
Awad H, Hubert GW, Smith Y, Levey AI, Conn PJ (2000) Activation of
metabotropic glutamate receptor 5 has direct excitatory effects and
potentiates NMDA receptor currents in neurons of the subthalamic
nucleus. J Neurosci 20:7871–7879.
Bashir ZI, Bortolotto ZA, Davies CH, Berretta N, Irving AJ, Seal AJ,
Henley JM, Jane DE, Watkins JC, Collingridge GL (1993) Induction
of LTP in the hippocampus needs synaptic activation of glutamate
metabotropic receptors. Nature 363:347–350.
Baude A, Nusser Z, Roberts JDB, Mulvihill E, McIlhinney RAJ, Somo-
gyi P (1993) The metabotropic glutamate receptor (mGluR1) is con-
centrated at perisynaptic membrane of neuronal subpopulations as
detected by immunogold reaction. Neuron 11:771–787.
Berthele A, Laurie DJ, Platzer S, Zieglgansberger W, Tolle TR, Sommer
B (1998) Differential expression of rat and human type I metabotropic
glutamate receptor splice variant messenger RNAs. Neuroscience
3:733–749.
Bianchi R, Young SR, Wong RK (1999) Group I mGluR activation
causes voltage-dependent and -independent Ca
2 rises in hippocampal
pyramidal cells. J Neurophysiol 81:2903–2913.
Bond A, Ragumoorthy N, Monn JA, Hicks CA, Ward MA, Lodge D,
O’Neill MJ (1999) LY379268, a potent and selective group II metabo-
tropic glutamate receptor agonist, is neuroprotective in gerbil global,
but not focal, cerebral ischaemia. Neurosci Lett 273:191–194.
Bond A, Jones NM, Hicks CA, Whifﬁn GM, Ward MA, O’Neill MF,
Kingstom AE, Monn JA, Ornstein PL, Schoepp DD, Lodge D, O’Neill
MJ (2000) Neuroprotective effects of LY379268, a selective mGlu2/3
receptor agonist: investigations into possible mechanism of action in
vivo. J Pharmacol Exp Ther 294:800–809.
Chapman AG, Nanan K, Williams M, Meldrum B (2000) Anticonvul-
sant activity of two metabotropic glutamate group I antagonists selec-
tive for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine
(MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neurophar-
macology 39:1567–1574.
Charpak S, Gahwiler BH, Do KQ, Knoepfel T (1990) Potassium con-
ductances in hippocampal neurons blocked by excitatory amino acid
transmitters. Nature 347:765–767.
Chu Z, Hablitz JJ (1998) Activation of group I mGluRs increases spon-
taneous IPSC frequency in rat frontal cortex. J Neurophysiol
80:621–627.
Clark BP, Baker SR, Goldsworthy J, Harris JR, Kingston AE (1997)
()-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antago-
nizes metabotropic glutamate mGluR1 receptors. Bioorg Med Chem
Lett 7:2777–2780.
Crepel V, Aniksztejn L, Ben-Ari Y, Hammond C (1994) Glutamate
metabotropic receptors increase a Ca
2-activated nonspeciﬁc cationic
current in CA1 hippocampal neurons. J Neurophysiol 72:1561–1569.
Davies CH, Clarke VR, Jane DE, Collingridge GL (1995) Pharmacol-
ogy of postsynaptic metabotropic glutamate receptors in rat hippocam-
pal CA1 pyramidal neurones. Br J Pharmacol 116:1859–1869.
Desai MA, Conn PJ (1991) Excitatory effects of ACPD receptor acti-
vation in the hippocampus are mediated by direct effects on pyramidal
cells and blockade of synaptic inhibition. J Neurophysiol 66:40–52.
Desai MA, McBain CJ, Kauer JA, Conn PJ (1994) Metabotropic gluta-
mate receptor-induced disinhibition is mediated by reduced transmis-
sion at excitatory synapses onto interneurons and inhibitory synapses
onto pyramidal cells. Neurosci Lett 181:78–82.
Ehlers MD (1999) Synapse structure: glutamate receptors connected by
the Shanks. Curr Biol 9:R848–R850.
Ferraguti F, Conquet F, Corti C, Grandes P, Kuhn R, Knoepfel T (1998)
Immunohistochemical localization of the mGluR1 metabotropic glu-
tamate receptor in the adult rodent forebrain: evidence for a different
distribution of mGluR1 splice variants. J Comp Neurol 400:391–407.
Fitzjohn SM, Irving AJ, Palmer MJ, Harvey J, Lodge D, Collingridge GL
(1996) Activation of group I mGluRs potentiates NMDA responses in
rat hippocampal slices. Neurosci Lett 203:211–213.
Fitzsimonds RM, Dichter MA (1996) Heterologous modulation of in-
hibitory synaptic transmission by metabotropic glutamate receptors in
cultured hippocampal neurons. J Neurophysiol 75:885–893.
Galoyan SM, Merlin LR (2000) Long-lasting potentiation of epilepti-
form bursts by group I mGluRs is NMDA receptor independent.
J Neurophysiol 83:2463–2467.
Gasparini F, Lingenho ¨hl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I,
Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, John-
son EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velic ¸elebi G, Kuhn
R (1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, se-
lective, and systemically active mGlu5 receptor antagonist. Neurophar-
macology 38:1493–1503.
Gereau 4th RW, Conn PJ (1995a) Multiple presynaptic metabotropic
glutamate receptors modulate excitatory and inhibitory synaptic trans-
mission in hippocampal area CA1. J Neurosci 15:6879–6889.
Gereau 4th RW, Conn PJ (1995b) Roles of speciﬁc metabotropic gluta-
mate receptor subtypes in regulation of hippocampal CA1 pyramidal
cell excitability. J Neurophysiol 74:122–129.
Guerineau NC, Gahwiler BH, Gerber U (1994) Reduction of resting K

Figure 8. Preapplication of the mGluR1 antagonist
LY367385 blocks the DHPG-induced increase in paired
pulse ratio (PPR). A, Consistent with previous studies, the
application of DHPG induces a signiﬁcant and reversible
enhancement of the PPR. This is evident both in the su-
perimposed scaled traces (top panel) and in the scatter plot
illustrating the effect of DHPG on the average PPR in each
experiment (bottom panel). The DHPG-induced increase
in PPR is not affected by preincubation with 10 M MPEP
(B) but is antagonized by the preapplication of 100 M
LY367385 (C). The traces represent averages of 40 EPSCs
before DHPG, superimposed on an average of four traces
obtained during the maximum DHPG effect. The traces are
scaled to the peak value of the ﬁrst EPSC to illustrate the
DHPG-induced change in facilitation.
Mannaioni et al. • Group I mGluRs and CA1 Pyramidal Function J. Neurosci., August 15, 2001, 21(16):5925–5934 5933current by metabotropic glutamate and muscarinic receptors in rat CA3
cells: mediation by G-proteins. J Physiol (Lond) 474:27–33.
Guerineau NC, Bossu JL, Gahwiler BH, Gerber U (1995) Activation of
a nonselective cationic conductance by metabotropic glutamatergic and
muscarinic agonists in CA3 pyramidal neurons of the rat hippocampus.
J Neurosci 15:4395–4407.
Hampson DR, Theriault E, Huang XP, Kristensen P, Pickering DS,
Franck JE, Mulvihill ER (1994) Characterization of two alternatively
spliced forms of a metabotropic glutamate receptor in the central
nervous system of the rat. Neuroscience 60:325–336.
Houamed KM, Kuijper JL, Gilbert TL, Haldeman BA, O’Hara PJ,
Mulvihill ER, Almers W, Hagen FS (1991) Cloning, expression, and
gene structure of a G-protein-coupled glutamate receptor from rat
brain. Science 252:1318–1321.
Joly C, Gomeza J, Brabet I, Curry K, Bockaert J, Pin J-P (1995) Molec-
ular, functional, and pharmacological characterization of the metabo-
tropic glutamate receptor type 5 splice variants: comparison with
mGluR1. J Neurosci 15:3970–3981.
Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, Roder
J (1997) Mice lacking metabotropic glutamate receptor 5 show im-
paired learning and reduced CA1 long-term potentiation (LTP) but
normal CA3 LTP. J Neurosci 17:5196–5205.
Luja ´n R, Nusser Z, Roberts JC, Shigemoto R, Somogyi P (1996) Peri-
synaptic location of metabotropic glutamate receptors mGluR1 and
mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur
J Neurosci 8:1488–1500.
Luthi A, Gahwiler BH, Gerber U (1996) A slowly inactivating potassium
current in CA3 pyramidal cells of rat hippocampus in vitro. J Neurosci
16:586–594.
Mannaioni G, Attucci S, Missanelli A, Pellicciari R, Corradetti R, Moroni
F (1999) Biochemical and electrophysiological studies on (S)-()-2-
(3
-carboxybicyclo[1.1.1]pentyl)-glycine (CBPG), a novel mGlu5 recep-
tor agonist endowed with mGlu1 receptor antagonist activity. Neuro-
pharmacology 38:917–926.
Marino MJ, Rouse ST, Levey A, Potter LT, Conn PJ (1998) Activation
of the genetically deﬁned m1 muscarinic receptor potentiates N-methyl-
D-aspartate (NMDA) receptor currents in hippocampal pyramidal
cells. Proc Natl Acad Sci USA 95:11465–11470.
Marino MJ, Risso Bradley S, Wittmann M, Conn PJ (1999) Direct
excitation of GABAergic projection neurons of the rat substantia nigra
pars reticulata by activation of the mGluR1 metabotropic glutamate
receptor. Soc Neurosci Abstr 25:446.
Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S (1991)
Sequence and expression of a metabotropic glutamate receptor. Nature
349:760–765.
McBain CJ, DiChiara TJ, Kauer JA (1994) Activation of metabotropic
glutamate receptors differentially affects two classes of hippocampal
interneurons and potentiates excitatory synaptic transmission. J Neu-
rosci 14:4433–4445.
Merlin LR (1999) Group I mGluR-mediated silent induction of long-
lasting epileptiform discharges. J Neurophysiol 82:1078–1081.
Miles R, Poncer JC (1993) Metabotropic glutamate receptors mediate a
post-tetanic excitation of guinea-pig hippocampal inhibitory neurones.
J Physiol (Lond) 463:461–473.
Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, Valtschanoff J, Weinberg RJ,
Worley PF, Sheng M (1999) Shank, a novel family of postsynaptic
density proteins that binds to the NMDA receptor/PSD-95/GKAP
complex and cortactin. Neuron 23:569–582.
Nakanishi S (1992) Molecular diversity of glutamate receptors and im-
plications for brain function. Science 258:597–603.
Pedarzani P, Storm JF (1993) PKA mediates the effects of monoamine
transmitters on the K
 current underlying the slow spike frequency
adaptation in hippocampal neurons. Neuron 11:1023–1035.
Pellegrini-Giampietro DE, Cozzi A, Peruginelli F, Leonardi P, Meli E,
Pellicciari R, Moroni F (1999) 1-Aminoindan-1,5-dicarboxylic acid
and (S)-()-2-(3
-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1
receptor-preferringantagonists, reduce neuronal death in in vitro and in
vivo models of cerebral ischemia. Eur J Neurosci 11:3637–3647.
Pin J-P, Duvoisin R (1995) The metabotropic glutamate receptors:
structure and functions. Neuropharmacology 34:1–26.
Pin J-P, Waeber C, Prezeau L, Bockaert J, Heinemann SF (1992) Alter-
native splicing generates metabotropic glutamate receptors inducing
different patterns of calcium release in Xenopus oocytes. Proc Natl
Acad Sci USA 89:10331–10335.
Pisani A, Calabresi P, Centonze D, Bernardi G (1997) Enhancement of
NMDA responses by group I metabotropic glutamate receptor activa-
tion in striatal neurones. Br J Pharmacol 120:1007–1014.
Pozzo-Miller LD, Petrozzino JJ, Golarai G, Connor JA (1996) Ca
2
release from intracellular stores induced by afferent stimulation of CA3
pyramidal neurons in hippocampal slices. J Neurophysiol 76:554–562.
Rodriguez-Moreno A, Sistiaga A, Lerma J, Sa ´nchez-Prieto J (1998)
Switch from facilitation to inhibition of excitatory synaptic transmission
by group I mGluR desensitization. Neuron 21:1477–1486.
Romano C, Sesma MA, McDonald CT, O’Malley K, van den Pol AN,
Olney JW (1995) Distribution of metabotropic glutamate receptor
mGluR5 immunoreactivity in rat brain. J Comp Neurol 355:455–469.
Schoepp DD, Conn PJ (1993) Metabotropic glutamate receptors in
brain function and pathology. Trends Pharmacol Sci 14:13–20.
Shigemoto R, Nakanishi S, Mizuno N (1992) Distribution of the mRNA
for a metabotropic glutamate receptor (mGluR1) in the central nervous
system: an in situ hybridization study in adult and developing rat.
J Comp Neurol 322:121–135.
Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M,
Flor PJ, Neki A, Abe T, Nakanishi S, Mizuno N (1997) Differential
presynaptic localization of metabotropic glutamate receptor subtypes
in the rat hippocampus. J Neurosci 17:7503–7522.
Stocker M, Krause M, Pedarzani P (1999) An apamin-insensitive Ca
2-
activated K
 current in hippocampal pyramidal neurons. Proc Natl
Acad Sci USA 96:4662–4667.
Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S (1992) A family
of metabotropic glutamate receptors. Neuron 8:169–179.
Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ,
Worley PF (1998) Homer binds a novel proline-rich motif and links
group I metabotropic glutamate receptors with IP3 receptors. Neuron
21:717–726.
Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Doan A,
Aakalu VK, Lanahan AA, Sheng M, Worley PF (1999) Coupling of
mGluR/Homer and PSD-95 complexes by the Shank family of postsyn-
aptic density proteins. Neuron 23:583–592.
van Hooft JA, Giuffrida R, Blatow M, Monyer H (2000) Differential
expression of group I metabotropic glutamate receptors in functionally
distinct hippocampal interneurons. J Neurosci 20:3544–3551.
5934 J. Neurosci., August 15, 2001, 21(16):5925–5934 Mannaioni et al. • Group I mGluRs and CA1 Pyramidal Function